SearchDictionaryMobileLogin Register FREE

Carbo-MVE protocol

Subscribe to Selected New Research on Carbo-MVE protocol
0  relevant articles (0 outcomes, 0 trials/studies) found for this Bio-Agent

Description: chemotherapy protocol consisting of the above cpds; used for treatment of transitional cell bladder carcinoma

Also Known As:
M-VECA protocol

Bio-Agent Context: Research Results

-
Therapeutics: 5195
-
Drug Therapy: 116609
-
Combination Drug Therapy: 8322
-
Antineoplastic Combined Chemotherapy Protocols: 16
*
Carbo-MVE protocol
-
Antineoplastic Protocols: 20
-
Antineoplastic Combined Chemotherapy Protocols: 16
*
Carbo-MVE protocol
-
Clinical Protocols
-
Antineoplastic Protocols: 20
-
Antineoplastic Combined Chemotherapy Protocols: 16
*
Carbo-MVE protocol
-
Heterocyclic Compounds: 23
-
Alkaloids: 633
-
Indole Alkaloids: 21
-
Secologanin Tryptamine Alkaloids: 49
-
Vinca Alkaloids: 279
-
Vinblastine: 2479
*
Carbo-MVE protocol
-
2-Ring Heterocyclic Compounds
-
Indoles: 69
-
Indole Alkaloids: 21
-
Secologanin Tryptamine Alkaloids: 49
-
Vinca Alkaloids: 279
-
Vinblastine: 2479
*
Carbo-MVE protocol
-
Pteridines: 30
-
Pterins: 38
-
Aminopterin: 222
-
Methotrexate: 11848
*
Carbo-MVE protocol
-
Organic Chemicals: 40
-
Hydrocarbons: 382
-
Cyclic Hydrocarbons: 2
-
Aromatic Hydrocarbons: 115
-
Aromatic Polycyclic Hydrocarbons: 581
-
Naphthacenes
-
Anthracyclines: 1290
-
Daunorubicin: 1725
-
Doxorubicin: 15007
-
Epirubicin: 2010
*
Carbo-MVE protocol
-
Organometallic Compounds: 5
-
Organoplatinum Compounds
-
Carboplatin: 4437
*
Carbo-MVE protocol
-
Polycyclic Compounds: 58
-
Aromatic Polycyclic Hydrocarbons: 581
-
Naphthacenes
-
Anthracyclines: 1290
-
Daunorubicin: 1725
-
Doxorubicin: 15007
-
Epirubicin: 2010
*
Carbo-MVE protocol
-
Carbohydrates: 2946
-
Glycosides: 339
-
Aminoglycosides: 1075
-
Anthracyclines: 1290
-
Daunorubicin: 1725
-
Doxorubicin: 15007
-
Epirubicin: 2010
*
Carbo-MVE protocol